Stocktoria

Relay Therapeutics, Inc. RLAY

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-16

Relay Therapeutics, Inc. statistics & valuation

Market cap$4.0B
P / B7.1×
Net margin-1800.6%
Return on equity-48.8%
FCF margin-1536.1%
Return on capital-50.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-63.40% -12012.90% -21036.10% -1338.70% -3374.70% -1800.60% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-67.50% -12040.20% -21670.90% -1460.10% -3722.10% -1971.60% 2019202020212022202320242025
Return on equity (%)
-6.90% -40.50% -30.60% -45.50% -43.40% -48.80% 2019202020212022202320242025
Shares outstanding
4.0M 89.9M 108.2M 121.1M 127.5M 167.8M 173.9M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-19.20% -6.60% -36.10% -26.40% -40.50% -38.80% -44.50% 2019202020212022202320242025
Free cash flow margin (%)
-126.30% -2571.00% -17273.90% -1191.70% -2509.50% -1536.10% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$5.40 -$3.82 -$2.59 -$2.79 -$2.36 -$1.61 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-1971.6%-3722.1%-1460.1%-21670.9%-12040.2%-67.5%—
Net margin-1800.6%-3374.7%-1338.7%-21036.1%-12012.9%-63.4%—
FCF margin-1536.1%-2509.5%-1191.7%-17273.9%-2571.0%-126.3%—
Return on assets-44.5%-38.8%-40.5%-26.4%-36.1%-6.6%-19.2%
Return on equity-48.8%-43.4%-45.5%-30.6%-40.5%-6.9%41.7%
Current ratio22.6115.9525.4416.0040.1456.4930.08

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.